Table 2.
Variation in testing and hospitalization based on CPG specific recommendations among infants ≤ 28 days of age with diagnosis of fever.
| Testing / Hospitalization | Hospitals, n | Patients, n | % Received1 | aOR (95% CI)2 | P-value2 |
|---|---|---|---|---|---|
| Laboratory Testing | |||||
| Urine testing3 | |||||
| No CPG | 13 | 996 | 75.6 | Ref | |
| CPG: Recommend for all | 20 | 2149 | 80.7 | 1.2 (0.9 - 1.7) | 0.22 |
| Blood testing4 | |||||
| No CPG | 13 | 996 | 76.9 | Ref | |
| CPG: Recommend for all | 20 | 2149 | 81.8 | 1.2 (0.9 - 1.7) | 0.25 |
| CSF testing5 | |||||
| No CPG | 13 | 996 | 71.0 | Ref | |
| CPG: Recommend for all | 20 | 2149 | 77.5 | 1.3 (1.0 - 1.7) | 0.08 |
| Disposition | |||||
| Hospitalization | |||||
| No CPG | 13 | 996 | 75.4 | Ref | |
| CPG: Recommend for all | 20 | 2149 | 81.6 | 1.2 (0.9 - 1.8) | 0.26 |
Abbreviations: CPG, clinical practice guideline; OR, odds ratio; CI, confidence interval; CSF, cerebrospinal fluid
% of infants who received test or were hospitalized
Adjusted for hospital clustering, geographic region, payer, race, and gender
Urine testing defined as urine dipstick, urinalysis, or urine culture
Blood testing defined as CBC or blood culture
CSF testing defined as cell count, culture, or procedure code for lumbar puncture